VC trades 6.3% below Wall Street's consensus target of $121.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VC achieves its forward estimates and maintains a stable P/E multiple of 13.3x. This scenario reflects the blended consensus of 23 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Visteon Corporation (VC) has a Wall Street consensus price target of $121.00, based on estimates from 23 covering analysts. With the stock currently trading at $113.81, this represents a potential upside of +6.3%. The company has a market capitalization of $3.05B.
Analyst price targets range from a low of $115.00 to a high of $135.00, representing a 17% spread in expectations. The median target of $119.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 16 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, VC trades at a trailing P/E of 15.6x and forward P/E of 13.3x. Analysts expect EPS to grow +17.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $131.32, with bear and bull scenarios of $82.73 and $173.03 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
APTVAptiv PLC | $13.5B | $63.68 | $88.63 | +39.2% | Buy | 10.3x | 33 |
LEALear Corporation | $7.1B | $139.75 | $134.86 | -3.5% | Hold | 9.4x | 31 |
MGAMagna International Inc. | $18.2B | $65.35 | $67.30 | +3.0% | Buy | 9.9x | 30 |
GNTXGentex Corporation | $5.6B | $25.95 | $26.00 | +0.2% | Buy | 13.0x | 20 |
PERIPerion Network Ltd. | $351M | $8.51 | $13.50 | +58.6% | Buy | 7.2x | 14 |
CAMPCAMP4 Therapeutics Corporation | $88M | $4.13 | $11.40 | +176.0% | Buy | — | 24 |
XPELXPEL, Inc. | $1.3B | $45.45 | $58.00 | +27.6% | Buy | 22.6x | 6 |
TXNTexas Instruments Incorporated | $294.0B | $322.86 | $274.06 | -15.1% | Buy | 41.9x | 65 |
NXPINXP Semiconductors N.V. | $79.1B | $313.27 | $242.60 | -22.6% | Buy | 21.3x | 46 |
ONON Semiconductor Corporation | $47.7B | $121.62 | $94.25 | -22.5% | Buy | 39.4x | 46 |
Quick answers to the most common questions about buying VC stock.
The consensus price target for VC is $121, close to the current price of $113.81 (6.3% implied move). Based on 23 analyst estimates, the stock appears fairly valued near current levels.
VC has a consensus rating of "Buy" based on 23 Wall Street analysts. The rating breakdown is predominantly bullish, with 16 Buy/Strong Buy ratings. The consensus 12-month price target of $121 implies 6.3% upside from current levels.
With a forward P/E of 13.3019x, VC trades at a relatively low valuation. The consensus target of $121 implies 6.3% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $135 for VC, while the most conservative target is $115. The consensus of $121 represents the median expectation. Our quantitative valuation model projects a bull case target of $173 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
VC is well covered by analysts, with 23 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VC stock forecast based on 23 Wall Street analysts shows a consensus price target of $121, with estimates ranging from $115 (bear case) to $135 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $131, with bear/bull scenarios of $83/$173.
Our quantitative valuation model calculates VC's fair value at $131 (base case), with a bear case of $83 and bull case of $173. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
VC trades at a forward P/E ratio of 13.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 15.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
VC appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $121 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VC analyst price targets range from $115 to $135, a 17% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $121 consensus represents the middle ground. Our model's $83-$173 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.